Public health impact of introducing adjuvanted recombinant zoster vaccine into the UK National Immunisation Programme

The above graphical abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online (see “read the peer-reviewed publication” opposite).